Atlas Trials

The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder

Clinical trial NCT05711862 · TERMINATED

Trial details

NCT number
NCT05711862
Sponsor
The University of Texas Health Science Center, Houston
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Methamphetamine Use Disorder
Start date
2023-03-09
Primary completion
2024-03-28
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.